BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23689000)

  • 41. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.
    Wada Y; Nakashima O; Kutami R; Yamamoto O; Kojiro M
    Hepatology; 1998 Feb; 27(2):407-14. PubMed ID: 9462638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis.
    Zheng X; Song X; Shao Y; Xu B; Chen L; Zhou Q; Hu W; Zhang D; Wu C; Tao M; Zhu Y; Jiang J
    Oncotarget; 2017 Aug; 8(34):57386-57398. PubMed ID: 28915679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
    Pruneri G; Gray KP; Vingiani A; Viale G; Curigliano G; Criscitiello C; Láng I; Ruhstaller T; Gianni L; Goldhirsch A; Kammler R; Price KN; Cancello G; Munzone E; Gelber RD; Regan MM; Colleoni M
    Breast Cancer Res Treat; 2016 Jul; 158(2):323-31. PubMed ID: 27372069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?
    Schnellhardt S; Erber R; Büttner-Herold M; Rosahl MC; Ott OJ; Strnad V; Beckmann MW; King L; Hartmann A; Fietkau R; Distel L
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-Infiltrating CD20
    Suárez-Sánchez FJ; Lequerica-Fernández P; Rodrigo JP; Hermida-Prado F; Suárez-Canto J; Rodríguez-Santamarta T; Domínguez-Iglesias F; García-Pedrero JM; de Vicente JC
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
    Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB
    J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.
    Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN
    Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association of tumor lymphocyte infiltration with clinicopathological factors and survival in breast cancer.
    Huszno J; Nożyńska EZ; Lange D; Kołosza Z; Nowara E
    Pol J Pathol; 2017; 68(1):26-32. PubMed ID: 28547977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Srivastava AN; Makker A; Goel MM
    Indian J Cancer; 2013; 50(3):239-44. PubMed ID: 24061465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma.
    Shi JY; Gao Q; Wang ZC; Zhou J; Wang XY; Min ZH; Shi YH; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Song K; Fan J
    Clin Cancer Res; 2013 Nov; 19(21):5994-6005. PubMed ID: 24056784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
    Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K
    Oncol Lett; 2021 Dec; 22(6):837. PubMed ID: 34712361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
    Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
    Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
    Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
    Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Factors for Breast Cancer: an Immunomorphological Update.
    Roncati L; Barbolini G; Piacentini F; Piscioli F; Pusiol T; Maiorana A
    Pathol Oncol Res; 2016 Jul; 22(3):449-52. PubMed ID: 26589512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
    Ono M; Tsuda H; Shimizu C; Yamamoto S; Shibata T; Yamamoto H; Hirata T; Yonemori K; Ando M; Tamura K; Katsumata N; Kinoshita T; Takiguchi Y; Tanzawa H; Fujiwara Y
    Breast Cancer Res Treat; 2012 Apr; 132(3):793-805. PubMed ID: 21562709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of tumour-infiltrating lymphocytes based on the evaluation of frequency in patients with oestrogen receptor-positive breast cancer.
    He J; Fu F; Wang W; Xi G; Guo W; Zheng L; Ren W; Qiu L; Huang X; Wang C; Li L; Kang D; Chen J
    Eur J Cancer; 2021 Sep; 154():217-226. PubMed ID: 34293665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
    Lukesová S; Vroblová V; Hlávková D; Kopecký O; Vokurková D; Morávek P; Safránek H; Soucek P
    Vnitr Lek; 2008 Feb; 54(2):139-45. PubMed ID: 23687704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis.
    Geng Y; Shao Y; He W; Hu W; Xu Y; Chen J; Wu C; Jiang J
    Cell Physiol Biochem; 2015; 37(4):1560-71. PubMed ID: 26513143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.